baber/WOPTO huggingface dataset:
Patent JP-2001506254-A (JP)
Title: チアゾール誘導体の製造方法
IPC: C07D417/06
Filed: 1997-12-17
Abstract: (57)【要約】
本発明は、ａ）式（II）の化合物をハロゲン化試薬と反応させて式（III）の化合物を形成するか、またはｂ）式（ＩＩ）の化合物をハロゲン化試薬により式(IV)の化合物に変換し、所望によりｃ）式（IV）の化合物を式（III）の化合物に変換し、ｄ）式（III）の化合物を式（Ｖ）の化合物により式（VI）の化合物に変換するか；またはｅ）式（IV）の化合物を式（Ｖ）の化合物により式（VI）の化合物に変換し、およびｆ）式（VI）の化合物を塩素化試薬により式（Ｉ）の化合物に変換することを含む式（Ｉ）（式中、Ｑ、Ｙ、Ｚ、Ｒ 1 、Ｒ 2 ，Ｒ 3 ，Ｒ 4 ，およびＲ 5 は、明細書中で定義される通り）の化合物の製造方法；化合物（VI）；および化合物（III）の製造方法、および化合物（IV）の製造方法に関する。
Patent JP-2001507166-A (JP)
Title: 直接供給燃料を使用する燃料電池用多層膜
IPC: B32B7/025
Filed: 1997-12-15
Abstract: (57)【要約】
少なくとも３層の陽イオン交換ポリマーの積層構造体を有する陽イオン交換膜。本発明による膜では、積層体中の陽イオン交換ポリマーは、ポリマー主鎖と、そのポリマー主鎖に結合する繰り返し側鎖に担持される陽イオン交換基とを有し、そのポリマー主鎖の炭素原子の数は、各層のイオン交換率（ＩＸＲ）を規定する陽イオン交換基と関係するものである。層は、１層または複数の高ＩＸＲ層と１層または複数の低ＩＸＲ層とをもたらす異なるＩＸＲ値を有し、低ＩＸＲ層のＩＸＲは約１７未満であり、および高ＩＸＲ層のＩＸＲは少なくとも約１５である。本発明による膜では、高い層および低い層は、膜の厚さを横切る少なくとも２箇所で、ＩＸＲに少なくとも約２の変化をさらにもたらす。
Patent JP-2001507297-A (JP)
Title: 特に、インキ転写スリーブ用に構成されたセラミックコーティング複合材料
IPC: B41N7/06
Filed: 1997-12-30
Abstract: (57)【要約】
特に、金属製の支持ローラに取り付けてインキ転写に使用されるように構成した複合スリーブである。このスリーブは、径方向に変形され得る基本スリーブ（１０）と、変形制限層（１２）と、径方向の変形を吸収する中間層（１４）と、セラミックコーティングした放熱容量が大きい材料の層（１６）とを含む。セラミックコーティング（１８）は、インキ溜め止め容量をスリーブの外面に与えて印刷機でアニロックス（ａｎｉｌｏｘ）として使用可能にするために、一般にはレーザでエッチングする。
Patent JP-H11505891-A (JP)
IPC: D05C17/02
Filed: 1996-05-17
Abstract: PCT No. PCT/GB96/01189 Sec. 371 Date Nov. 24, 1997 Sec. 102(e) Date Nov. 24, 1997 PCT Filed May 17, 1996 PCT Pub. No. WO96/37645 PCT Pub. Date Nov. 28, 1996A yarn for a floor textile material which is comprised of a coarse yarn and a fine yarn twisted together for tufting into a backing material to provide a floor mat. The finer yarn has fibers in the range of 32 to 100 decitex while the coarser yarn has fibers in the range of 110-290 decitex.
Patent JP-2001501524-A (JP)
IPC: C07C211/10
Filed: 1996-05-29
Abstract: This invention includes catalysts comprising rhenium (atomic number 75), nickel, cobalt, boron and copper and/or ruthenium impregnated on a support material and a process for preparing said catalyst, said process comprising (i) impregnating a mixture of metals comprising rhenium, cobalt, copper and/or ruthenium, boron and nickel on a support material selected from the group consisting of alpha-alumina, silica, silica-alumina, kiesolguhrs or diatomaceous earths, and silica-titanias; and (ii) activating said catalyst by heating the catalyst in the presence of hydrogen at an effective temperature preferably in the range of about 150 DEG  C. to about 500 DEG  C. for a sufficient period preferably of from about 30 minutes to about 6 hours. A further feature of the present invention is a method for producing amine products by the catalytic amination of alkane or arylalkane derivatives including epoxides, monols, diols, polyethers, polyols, alcoholamines, ketones, imino compounds iminoalcohols, ether alcohols, and mixtures thereof, said process comprising contacting said lower alkane or arylalkane derivatives with ammonia and/or reactant amine at an effective temperature preferably from 150 DEG  C. to about 500 DEG  C. and in the presence of hydrogen and the nickel-rhenium-cobalt-boron-copper and/or ruthenium catalyst as described hereinabove.
Patent JP-2002506427-A (JP)
IPC: A61K31/549
Filed: 1998-04-28
Abstract: Certain derivatives of acridones and benzothiadiazines have been found to have anti-cancer properties by virtue of their specific inhibition of the cyclin D dependant kinase CDK4. These molecules inhibit CDK4 activity more than they inhibit the activity of other such kinases (e.g. CDC2 and CDK2). This specificity results in an improved therapeutic index when used as drugs to treat susceptible cancers.
Patent MD-20020285-A (MD)
Title: Solar heat supply installation
Inventor: MARCO Gavril
IPC: F24S90/00
Filed: 2002-11-29
Abstract: The invention refers to the solar heat supply installations and may be used for industrial and household purposes.Summary consists in that the installation contains a solar receiver 1, a thermostat 2 installed at the outlet from the receiver and meant for maintenance at a constant temperature of the heat-transfer agent, a pressure tank 3, which is installed on a higher level and a storage tank 4, and all the elements are connected in circuit with the help of the pipe-lines 5, 6.
Patent MX-152740-A (MX)
Inventor: LOHRBERG KARL
IPC: C25B15/08
Filed: 1979-08-02
Abstract: An improvement in a process of electrolyzing an aqueous solution of an alkali metal halide in a membrane cell in which a pH above 1.0 is maintained in the anode chamber, the alkali metal halide solution is removed from the anode chamber and its concentration and pH are increased is described. The improvement resides in thereafter decreasing the pH of at least a portion of the resultant solution to below 1.0 and thereafter adjusting the pH to 1.0 to 6.0 and returning the so adjusted solution to the anode chamber.
Patent MX-161814-A (MX)
Inventor: MARSCH HANS DIETER
IPC: B01J8/06
Filed: 1983-11-30
Abstract: 1. Device for the generation of a product gas containing hydrogen and carbon oxides from a feedgas consisting substantially of hydrocarbons, particularly natural gas, to which steam is admixed by a) catalytic endothermic reforming of said feedgas to a product gas in catalyst-filled reaction tubes (4) b) partial combustion of the reformed gas from the reaction tubes (4) by means of oxygen and/or oxygen-bearing gas in a reactor (2) divided by a partition plate (21) into two discrete sections, an upper chamber (3) containing a feedgas inlet ; and a lower chamber (24) with free space (6) beyond, the reactor containing catalyst-filled reaction tubes (4) attached to the partition plate (21) by a gas-tight seal and extending from the chamber (3) into said space (6) characterized in that the wall of the lower chamber and/or the floor of the lower chamber are equipped with jet tubes (28) and permeable, porous ceramic plates (29) directed towards the free space for the ducting of additional reaction agents into said space.
Patent NZ-213637-A (NZ)
Title: Buffered glutaraldehyde sterilising and disinfecting compositions
Inventor: JACOBS P T
IPC: A01N35/02
Filed: 1985-09-27
Abstract: A glutaraldehyde. sterilizing and. disinfecting solution which is hard water compatible and which contains a nitrilo tris (ethyl phosphoric acid) salt as a buffering agent
Patent NZ-213717-A (NZ)
Title: Synthetic signal sequence for transport of proteins in expression systems
Inventor: ENGELS J
IPC: C12R1/19
Filed: 1985-10-04
Abstract: The DNA of a natural signal sequence is modified by incorporation of cleavage sites for endonucleases and is thus made suitable for incorporation in any desired vectors by the building block principle. The vectors modified in this way then bring about transport of the encoded protein out of the cytoplasm. <IMAGE>
Patent NZ-254123-A (NZ)
Title: Automated running of sports events utilising machine readable data tokens
Inventor: EIBA PETER
IPC: G07F17/32
Filed: 1993-07-09
Abstract: PCT No. PCT/EP93/01001 Sec. 371 Date Jan. 11, 1995 Sec. 102(e) Date Jan. 11, 1995 PCT Filed Jul. 9, 1993 PCT Pub. No. WO94/01839 PCT Pub. Date Jan. 20, 1994A system for automated running of sports contests including a computer unit, a machine-readable data carrier for each such contestant, a data carrier containing control data for each type of contest to be performed, and at least one reader for the data carrier. Contestant data and control data are exclusively input into the computer unit using the data carriers. At least one display device linked to the computer unit displays contest data. The individual phases of the contest running may be determined by the sequence of the data carriers introduced in the reader(s).
Patent NZ-256871-A (NZ)
Title: 4-quinolinyl derivatives and medicaments
Inventor: VENET MARC GASTON
IPC: A61K31/47
Filed: 1993-10-19
Abstract: PCT No. PCT/EP93/02884 Sec. 371 Date Apr. 4, 1995 Sec. 102(e) Date Apr. 4, 1995 PCT Filed Oct. 19, 1993 PCT Pub. No. WO94/10164 PCT Pub. Date May 11, 1994The present invention is concerned with novel quinoline derivatives having anti-Helicobacter activity of formula    <IMAGE>  (I)  the pharmaceutically acceptable acid addition salts thereof, the stereochemically isomeric forms thereof, the quaternized forms thereof and the +E,uns N+EE -oxides thereof, wherein -A- represents a bivalent radical of formula -N=CH-CH=CH-(a), -CH=N-CH=CH-(b), -N=N-CH=CH-(c), -N=CH-N=CH-(d), -N=CH-CH=N-(e), -CH=N-N=CH-(f), -N=N-N=CH-(g), -N=N-CH=N-(h), or -CH=CH-CH=CH-(i); R1, R2, R3, R4, R5, R6 and R7 each independently represent hydrogen, halo, hydroxy, C1-4alkyloxy, C1-4alkyl, trifluoromethyl, amino, mono- or di(C1-4alkyl)amino or nitro, provided that when one substituent on a phenyl group is a nitro then the other substituents on said phenyl group are other than nitro; novel compositions comprising said compounds, processes of preparing said compounds and compositions and methods for treating subjects suffering from disorders or afflictions associated with Helicobacter infection.
Patent NZ-294397-A (NZ)
Title: Cloning of an insulin-dependent membrane aminopeptidase designated GTVap from GLUT-4 vesicles
Inventor: CLAIRMONT KEVIN
IPC: C12N9/48
Filed: 1995-09-19
Abstract: The specification describes an aminopeptidase, designated GTVap, which cleaves insulin.  GTVap has been purified from GLUT-4-containing vesicles and cloned. The peptidase has a measured mass of approximately 165 kD, but is 110 kD in its deglycosylated state. It has a predicted mass of 117,239 Daltons based on the amino acid sequence predicted from the cDNA of the figure (SEQ ID NOs: 15 and 16). It includes peptides having the amino acid sequences Phe-Ala-Ala-Thr-Gln-Phe-Glu-Pro-Leu-Ala-Ala (SEQ ID NO: 1) and Ile-Leu-Gln-Asn-Gln-Ile-Gln-Gln-Gln-Thr-Arg-Thr-Asp-Glu-Gly-Xaa-Pro-Xaa-Met (SEQ ID NO: 2), and binds with antibodies produced against the peptide identified as (SEQ ID NO: 1). Modulators of the activity of the aminopeptidase and a method for treating syndromes of insulin resistance, including diabetes, by administration of such a modulator are also claimed.
Patent NZ-296564-A (NZ)
Title: Method of improving antigenicity of antigens or haptens, fusion with rsv peptides; vaccines, vectors, nucleotides
Inventor: BINZ HANS
IPC: A61K48/00
Filed: 1995-11-07
Abstract: A complex of an immunogen and a support molecule, characterized in that the immunogen is coupled covalently to a support molecule, wherein the support molecule is a polypeptide fragment which is able to bind specifically to mammalian serum albumin is disclosed. The invention also relates to the use of such complexes to treat RSV infection, as well as vaccines derived from such complexes.
Patent NZ-314183-A (NZ)
Title: Invalids bed comprising slat base members moved by a motor driven cam
Inventor: COSANI ADOLFO
IPC: A61G7/057
Filed: 1997-02-04
Abstract: An apparatus in the form of a bed or chair for providing relaxation therapy and prevention of decubitis sores is distinguished by the use of flexible beams (2) of the nature of leaf springs. Instead of being lifted up and down by rather complex apparatus only a single shaft (3) carrying cams (4) is provided which acts on the leaf spring-like beams to flex them upwardly and/downwardly to provide the required action. Preferred cams provide no lifting action but only intermitted depressing action of these beams which reduces vertigo and nausea effects and can be slid onto a cam shaft in any one of a multiple alternative angular positions. This enables selection of the travelling wave action for relaxation therapy and of the decubitis preventing action. <IMAGE>
Patent NZ-331324-A (NZ)
Title: Updated address for network name site retrieved from service control point
Inventor: HARRIS STEPHEN
IPC: H04L29/12
Filed: 1997-02-07
Abstract: ommunications are established between a source user (305) and a destination user (307). Data is transmitted between these users in packets (204) having a destination address (205) and communication data (206). A destination name is identified in a first packet and this packet is transmitted to a service control platform (301) identifying, in its communication data, a destination name. A packet is then returned from the control platform (301) to the originating source (305) identifying a real contactable address including a network address portion and a gateway address portion for the identified destination (307). Subsequent packets of data are generated at the source (305) for transmission to the destination (307) wherein the transmitted packets have the actual destination address, as returned from the service platform, appended thereto.
Patent NZ-334654-A (NZ)
Title: A process for amplifying DNA using a thermostable DNA polymerase from Anaerocellum thermophilum characterised in that it works in the presence of magnesium ions and the absence of manganese ions
Inventor: ANKENBAUER WALTRAUD
IPC: C12N5/10
Filed: 1997-10-01
Abstract: A process for amplifying DNA, characterised in that a thermostable DNA polymerase is used that is obtainable from Anaerocellum thermophilum that catalyses the template directed polymerisation of DNA.  The polymerase possess 5'-3'-exonuclease activity and a reverse transcriptase activity in the presence of magnesium ions and in the absence of manganese.  The polymerase also exhibits a Mg2+ dependent reverse transcriptase activity of more than 30% relative to the DNA polymerase activity which is set to 100%.
Patent NZ-335821-A (NZ)
Title: Gel formulation for topical drug delivery comprising 4-amino-2-ethoxymethyl-alpha,alpha-dimethyl-1H-imidazo[4,5-c]quinoline-1-ethanol, colloidal silicon dioxide, PEG and triacetin
Inventor: BEAURLINE JOSEPH MICHAEL
IPC: A61P17/00
Filed: 1997-12-01
Abstract: The gel formulation for topical administration of 4-amino-2-ethoxymethyl-a,a-dimethyl-1H-imidazo[4,5-c]quinoline -1-ethanol, comprises: (a) a therapeutically effective amount of 4-amino-2-ethoxymethyl-a,a-dimethyl-1H-imidazo[4,5-c]quinoline -1-ethanol; (b) 7% to 12% by weight of colloidal silicon dioxide; (c) 1% to 30% by weight of propylene glycol; and (d) 58% to 92% by weight of triacetin.
Patent NZ-337478-A (NZ)
Title: Inhalation device with accumulated powder on surface of flow path dislodged by vibration
Inventor: ANDERSSON JAN
IPC: A61M11/00
Filed: 1998-03-13
Abstract: The powder inhaler has body 6 with mouth piece 6 rotatably attached. Components 66,68 are movable relative to each other so as to create vibrations to dislodge powder accumulated on a surface of a flow path.
Patent NZ-507746-A (NZ)
Title: Vacuum cleaner bag and improved vacuum cleaner bag
Inventor: SCHULTINK BAS
IPC: B01D39/18
Filed: 1999-05-11
Abstract: A disposable vacuum filter bag is constructed of layers which include a high-air-permeability first layer positioned upstream in the direction of air flow of a second filtration layer. The second filtration layer can be a meltblown fleece, a wet-laid filter paper, a dry-laid filter paper or a spunbond nonwoven. The first layer can be made of a high-bulk meltblown nonwoven, dry-laid or wet- laid high-dust-capacity paper, spunblown modular nonwoven or microdenier spunbond nonwoven. A filter and a method for removing particles entrained in a gas where the filter has the same type of constructional features as the disposable vacuum filter bag are also disclosed.
Patent NZ-508102-A (NZ)
Title: Method and apparatus for containing and agitating the contents of a container using contra-rotating drum sections
Inventor: MONTEIRO ANDRE FRASER
IPC: B01F29/60
Filed: 1999-05-11
Abstract: An apparatus for containing a plurality of articles (22) within a defined space and for causing agitation between the articles (22), comprising a drum (12) for receiving the articles (22) and for delimiting the defined space, and drive means (24a, 24b) for rotating the drum (12) so as to cause agitation between the articles (22).  The drum (12) comprises at least two rotatable portions (16a, 16b) and the drive means (24a, 24b) are capable of rotating the drum (12) in such a manner that relative rotation is produced between adjacent rotatable portions (16a, 16b).
Patent NZ-510755-A (NZ)
Title: Method and apparatus for winding a helical pipe from its inside
Inventor: MENZEL STANLEY WILLIAM OTTO
IPC: F16L57/00
Filed: 1999-09-22
Abstract: A machine (200) for winding a strip of material (212) into a helical pipe wherein adjacent convolutions of the strip (212) are interlocked. The machine comprises: a frame (220) having circumferentially spaced supports in the form of rollers (266, 276, 278, 286, 288, 296 and 298) adapted to bear against the inner periphery of the pipe being wound, the outer peripheral surfaces of the rollers forming a helical path for the strip (212) and along which the strip (212) is directed when the machine (200) is in use; driving rollers (224) mounted to the frame (220) for driving the strip (212) around the outside of the rollers so as to follow the helical path and cause the adjacent edges of the strip (212) to interlock; and drive means (226) mounted to the frame for driving the driving rollers (224). The driving rollers (224) and the drive means are located wholly inside of the path formed by the rollers and no part of the machine (200) engages the outer periphery of the pipe being wound.
Patent NZ-511941-A (NZ)
Title: Use of Mycobacterium phlei DNA in chemotherapeutic compositions
Inventor: PHILLIPS NIGEL C
IPC: A61K31/711
Filed: 1999-12-03
Abstract: Use of Mycobacterium phlei DNA (optionally preserved and complexed on Mycobacterium phlei cell wall) and a chemotherapeutic agent to induce cell cycle arrest in cancer cells.
Patent NZ-513915-A (NZ)
Title: Chimeric proteins comprising 6 contiguous amino  acids that bind to the GIT fused to a second protein, which may be a drug
Inventor: PATTERSON CATHERINE A
IPC: A61K38/02
Filed: 1998-05-15
Abstract: A  chimeric protein comprising at least six contiguous amino   acids of  an  amino  acid  sequence   that   binds specifically  to  a gastro-intestinal tract  (GIT)  receptor selected from the group consisting of HPT1, hEPT1,  D2H  and hSI  is  disclosed.   The nucleotide sequence  encoding  the chimeric protein is also disclosed. Also  described  is  a  composition  comprising  a chimeric protein  bound to a material comprising an active agent,  in which  the chimeric protein comprises a sequence that  binds specifically  to  the group consisting of HPT1,  hEPT1,  D2H and  hSI fused via a covalent bond to an amino acid sequence of  a  second protein, in which the active agent is of value in the treatment of a mammalian disease or disorder.
Patent NZ-516328-A (NZ)
Title: Method and apparatus for sensing and assessing properties of powdered or particulate materials
Inventor: DAVIES CLIVE ERIC
IPC: G01N3/06
Filed: 2001-12-21
Abstract: Disclosed herein is an apparatus and a method for assessing properties such as flowability property of powdered or particulate material, wherein the method comprises: containing the material within, or causing the material to flow through, a rotating vessel (10) or chamber supported via a sensor indicative of force or weight; monitoring an output signal from the sensor as the container or vessel rotates and the material within the container or vessel moves; and assessing the material property by reference to the output signal of the sensor; wherein the sensor indicative of force or weight may be a load cell (19).
Patent NZ-517743-A (NZ)
Title: Production of toxic proteins in host cells by expressing as a fusion protein to chaperonin binding domains from GroES in the presence of a chaperonin GroEL
Inventor: JOACHIMIAK ANDRZEJ
IPC: C12N15/70
Filed: 2000-12-14
Abstract: A method for producing a protein in a host cell comprises the step of culturing a host cell comprising a first nucleic acid encoding an isolated chaperonin binding domain associated with a second nucleic acid encoding the protein and a third nucleic acid encoding a chaperonin. The chaperonin binding domain is capable of binding to the chaperonin. The cell is cultured under conditions suitable for expression of the first, second and third nucleic acids. Preferably the chaperonin binding domain is obtained form GroES and the chaperonin is the GroEL chaperonin.
Patent NZ-518532-A (NZ)
Title: Transgenic plant expressing mammalian beta-1,4- galactosyltransferase
Inventor: BAKKER HENDRIKUS ANTONIUS CORN
IPC: C12N15/82
Filed: 2000-10-26
Abstract: A plant comprises a gene capable of expressing a mammalian beta 1,4-galactosyl transferase enzyme or functional fragment thereof providing N-glycan biosynthesis via the addition of at least one galactose residue in b 1,4 linkage to plant N-linked glycans to produce an extended N- linked glycan. Preferably the extended N-linked glycan also exhibits reduced xylose content, reduced fructose content or further comprises sialic acid or glucuronyl or glucuronic acid. The plant can also comprise a second protein, which preferably comprises a mammalian antibody chain. Also described is a method for producing the transgenic plant and a method for obtaining a desired glycoprotein from the plant. The glycoprotein can be used in a pharmaceutical composition.
Patent NZ-519114-A (NZ)
Title: Tracking repetitive and unpredictable objects using a database having a spatiotemporal index
Inventor: WERSTEIN PAUL FRANCIS
IPC: G06F17/30
Filed: 2002-05-23
Abstract: A method of tracking repetitive, unpredictable moving objects includes the use of a database which stores and retrieves the position of multiple moving objects traveling at variable speeds and on variable paths characterised by a spatiotemporal index for fast, efficient retrieval of data based on its location. The method further includes partitioning the data space uniformly by the area covered.
Patent NZ-519963-A (NZ)
Title: Gypsum compositions with enhanced resistance to permanent deformation comprisng organic polyphosphonic compounds and/or a borate comprinsing ulexite or colemanite
Inventor: VEERAMASUNENI SRINIVAS
IPC: C04B22/14
Filed: 2001-04-11
Abstract: A set gypsum-containing composition comprises an interlocking matrix of the set gypsum formed from at least calcined gypsum, water and an enhancing material. The enhancing material comprises (i) an organic polyphosphonic compound or a mixture of polyphosphonic compounds or (ii) a borate comprising ulexite, colemanite or mixtures thereof, or a mixture of (i) and (ii). Also described is a set gypsum-containing composition wherein the set gypsum is treated with a mixture of a liquid and an enhancing material comprisng (i) an organic polyphosphonic compound or a mixture of polyphosphonic compounds, (ii) a borate comprising ulexite, colemanite or mixtures thereof (iii) a carboxylic compound or mixture of carboxylic compounds; or a mixture of (i), (ii) and (iii). A gypsum board may comprise the compositions described. An accelerator for an aqueous calcined gypsum composition comprises a borate and an accelerator material, preferably the accelerator material is calcium sulfate dihydrate.
Patent NZ-522428-A (NZ)
Title: Fuel cell adapter, for combustion tools, with base engaging with fuel cell and lobed end nozzle engaging with fuel metering valve
Inventor: TAYLOR WALTER J
IPC: B25C1/04
Filed: 2002-11-06
Abstract: Fuel cell adapter 16 has base 22 adapted for engagement to fuel cell 14 and nozzle 20 with a lobed free end configured for facilitating engagement upon a fuel metering valve of a combustion tool.
Patent NZ-522649-A (NZ)
Title: Solution stable low amylose tapioca starch and its use
Inventor: TAYAL AKASH
IPC: C08B35/00
Filed: 2002-11-20
Abstract: Use of low amylose tapioca starch for improved solution stability; process for the preparation thereof; use thereof in paper products, food products, pharmaceutical products.
Patent NZ-526132-A (NZ)
Title: Gate clip comprising of two leg portions connected by a central portion which can be clipped around part of a gate
Inventor: HAGENSON LEO
IPC: A01K3/00
Filed: 2003-05-27
Abstract: A gate clip is disclosed which includes two leg portions connected to on another by a central portion. The leg portions and the central portions are formed form a resilient, electrically insulated material. The outer side of the leg portions and the central portion includes a channel arranged to house a wire. The inner side of the central portion defines an aperture enabling the gate clip to be clipped around part of a gate.